Pfizer completes Hospira deal; Synedgen manufacturing director publishes research; Nigeria adds drug warehouse;

> Pfizer ($PFE) has completed its $15 billion buyout of Hospira. Release

> Synedgen Director of Manufacturing Christopher Ryan contributed to research with the CDC and universities on Trichomonas vaginalis. Release

> Nigeria is building a "warehouse in a box" to help the country deal with drug-distribution problems. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.